Under-fire James Murdoch is to remain as a non-executive director to GlaxoSmithKline. According to a GSK spokesperson, "With regard to the activities that are alleged to have taken place at News International, we believe that the full facts must be established and the ongoing investigations be allowed to take place and come to a considered conclusion,"
Murdoch, who is the heir to his father, Rupert's, News Corp, was said to have made a "a strong contribution" in joining Glaxo's board in 2009.
James Murdoch was paid £98,000 in shares for serving on GSK's board in 2010. He is member of both GSK's corporate responsibility and remuneration committees.
"We believe that the full facts must be established and the ongoing investigations be allowed to take place and come to a considered conclusion."
It's a pity Glaxo don't take that position when applying for a licence for drugs such as Seroxat [Paxil] and Avandia.
Pharma Giles has a great parody of recent affairs up on his blog, it's entitled, "The Dilemma Of St. Andrew..."
Another interesting post has appeared on the COTO Report website. They write:
Andrew Wakefield was a respected British gastroenterologist who began research into digestive problems in autistic children in collaboration with other doctors in the UK, after being called by parents seeking help. His work indicated severe digestive issues and he asked for more investigation of the MMR vaccine.
Brian Deer is the reporter who savaged Dr Wakefield from the pages of the Sunday Times, a paper managed by Rupert Murdoch’s son James Murdoch who is on the board of GlaxoSmithKline which makes the MMR.
It appears that there are a number of interesting weeks ahead for GlaxoSmithKline.
Coming soon - My open email to Glaxo's CEO, Andrew Witty regarding his snubbing of thousands of Seroxat patients. It's a long post and I'm just adding the finishing touches.
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
US & CANADA HERE OR UK FROM CHIPMUNKA PUBLISHING
AUSTRALIAN ORDERS HERE